BIOMAT Database Logo BIOMAT Database Logo

[Synthesis of N-acetyl-muramyl-dipeptide--an immunoadjuvant]. 1982

Z Y Chen, and L F Chen, and X Q Gong

UI MeSH Term Description Entries
D000119 Acetylmuramyl-Alanyl-Isoglutamine Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity. Mur-NAc-L-Ala-D-isoGln,Muramyl Dipeptide,Acetylmuramyl Alanyl Isoglutamine,N-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-Amide,N-Acetylmuramyl-L-Alanyl-D-Isoglutamine,Alanyl Isoglutamine, Acetylmuramyl,Dipeptide, Muramyl,Isoglutamine, Acetylmuramyl Alanyl,Mur NAc L Ala D isoGln,N Acetyl Muramyl L Alanyl D Glutamic alpha Amide,N Acetylmuramyl L Alanyl D Isoglutamine
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

Z Y Chen, and L F Chen, and X Q Gong
Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
October 1978, Experientia,
Z Y Chen, and L F Chen, and X Q Gong
Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide.
February 1982, Infection and immunity,
Z Y Chen, and L F Chen, and X Q Gong
Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
June 1975, Biken journal,
Z Y Chen, and L F Chen, and X Q Gong
Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
October 1978, Zeitschrift fur Immunitatsforschung. Immunobiology,
Z Y Chen, and L F Chen, and X Q Gong
Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine).
April 1978, International journal of peptide and protein research,
Z Y Chen, and L F Chen, and X Q Gong
N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
January 1982, Infection and immunity,
Z Y Chen, and L F Chen, and X Q Gong
Syntheses of polymeric vesicles containing partial structures of N-acetyl-muramyl-dipeptide (MDP).
March 1990, Chemistry and physics of lipids,
Z Y Chen, and L F Chen, and X Q Gong
Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.
January 1979, International journal of immunopharmacology,
Z Y Chen, and L F Chen, and X Q Gong
Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs.
January 1977, International journal of peptide and protein research,
Z Y Chen, and L F Chen, and X Q Gong
Effect of quinonyl-N-acetyl muramyl dipeptide on immune responses in tumor-bearing mice.
January 1983, Infection and immunity,
Copied contents to your clipboard!